Orion Capital Management LLC
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1846758
CORONADO, CA
Position in ALNY
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$648,719
-$295,914 QoQ
Shares Held
2,155
-24.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.54%
of 13F equity value
Holder Rank
#455
of 784 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Orion Capital Management LLC holds $1,139,867 across 8 Biotechnology names. ALNY ranks #1 (56.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,155 | $648,719 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
4,300 | $336,561 | |
| 3 | ORKA |
Oruka Therapeutics, Inc.
|
953 | $90,697 | |
| 4 | CRMD |
CorMedix Inc.
|
3,000 | $23,550 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
300 | $16,362 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
32 | $15,895 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
80 | $6,343 | |
| 8 | FTRE |
Fortrea Holdings Inc.
|
100 | $1,740 |
All Filings in ALNY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $648,719 | 2,155 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $944,633 | 2,855 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,179,827 | 2,967 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,431,840 | 3,140 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,056,531 | 3,240 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $901,866 | 3,340 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $785,935 | 3,340 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $941,977 | 3,425 | Shares | Sole | 2024-11-18 | |
| 2024-06-30 | $868,725 | 3,575 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $549,228 | 3,675 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $703,431 | 3,675 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $650,842 | 3,675 | Shares | Sole | 2023-11-16 | |
| 2023-06-30 | $755,011 | 3,975 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $796,272 | 3,975 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $951,788 | 4,005 | Shares | Sole | 2023-01-23 | |
| 2022-09-30 | $835,668 | 4,175 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $855,410 | 5,865 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,071,998 | 6,565 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,130,250 | 6,665 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,260,306 | 6,675 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $1,131,546 | 6,675 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $942,443 | 6,675 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $867,549 | 6,675 | Shares | Sole | 2021-02-23 | |
| No filing history on record for this holder in this stock. | ||||||